Cargando…
Therapeutic effects and safety of oral Chinese patent medicine for COVID-19: A rapid systematic review and meta-analysis of randomized controlled trials
INTRODUCTION: Chinese patent medicine (CPM) is an indispensable part of traditional Chinese medicine. Coronavirus Disease 2019 (COVID-19) manifests is an acute respiratory infectious disease. This systematic review aimed to evaluate the therapeutic effects and safety of oral CPM for COVID-19. METHOD...
Autores principales: | Liang, Shi-Bing, Fang, Min, Liang, Chang-Hao, Lan, Hui-Di, Shen, Chen, Yan, Li-Jiao, Hu, Xiao-Yang, Han, Mei, Robinson, Nicola, Liu, Jian-Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8180349/ https://www.ncbi.nlm.nih.gov/pubmed/34091029 http://dx.doi.org/10.1016/j.ctim.2021.102744 |
Ejemplares similares
-
Therapeutic effects and safety of oral Chinese patent medicine for COVID-19: A rapid systematic review and meta-analysis of randomized controlled trials
por: Liang, Shi-Bing, et al.
Publicado: (2021) -
Comparative efficacy, safety and cost of oral Chinese patent medicines for rheumatoid arthritis: a Bayesian network meta-analysis
por: Zhang, Dan, et al.
Publicado: (2020) -
Efficacy and Safety of Oral Chinese Patent Medicine Combined with Conventional Therapy for Heart Failure: An Overview of Systematic Reviews
por: Lin, Shan-Shan, et al.
Publicado: (2020) -
Clinical application of oral Chinese Patent Medicines in ophthalmology: a scoping review protocol
por: Xu, Kai, et al.
Publicado: (2022) -
Effect and safety of oral Chinese patent medicine for heart failure: A protocol for systematic review and network meta-analysis
por: Guan, Hui, et al.
Publicado: (2020)